A Feasible, Simple, Cost-Saving Program to End Cardiovascular Disease in the United States - 12/12/19
Doi : 10.1016/j.amjmed.2019.03.043
David S. Schade, MD a, ⁎ 
, S. Scott Obenshain, MD b, Barry Ramo, MD c, R. Philip Eaton, MD a
, S. Scott Obenshain, MD b, Barry Ramo, MD c, R. Philip Eaton, MD a a Division of Endocrinology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque
b Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque
c Medical Director, New Heart Fitness and Health, Albuquerque, NM
⁎Requests for reprints should be addressed to David S. Schade, MD, UNM SOM INT MED MSC10 5550, 1 Univ of NM, Albuquerque, NM 87131.UNM SOM INT MED MSC10 5550, 1 Univ of NMAlbuquerqueNM87131
El texto completo de este artículo está disponible en PDF.
Esquema
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2019
Elsevier Inc. Reservados todos los derechos.
Vol 132 - N° 12
P. 1365-1367 - décembre 2019 Regresar al número
Artículo precedente
- Take-Home Messages From the Recently Updated AHA/ACC Guidelines for Atrial Fibrillation
- Joseph S. Alpert
- A Benign Invasive Procedure: The Biopsychosocial Biopsy
- Michael W. Kahn
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?